Sandostatin (octreotide acetate) — United Healthcare
Bleeding gastroesophageal varices associated with liver disease
Initial criteria
- Diagnosis of bleeding gastroesophageal varices associated with liver disease
Reauthorization criteria
- Documentation of positive clinical response to Sandostatin therapy
Approval duration
12 months